Results 151 to 160 of about 55,614 (218)

Quality of different brands of clarithromycin tablets marketed in Ethiopia; implications for the future. [PDF]

JAC Antimicrob Resist
Bayu WT, Ketema G, Kassahun H, Meyer JC, Godman B, Mekonnen BA.   +5 more
europepmc   +1 more source

Comparative molecular profiling of Helicobacter pylori infection and antibiotic genotypic resistance in paired gastric mucosa, gastric juice, and stool samples. [PDF]

Sci Rep
Cheng J, Fan C, Zhao X, Li Z, Xie D, Cai Y, Huang K, Yang M, Wang H.   +8 more
europepmc   +1 more source

Implications of empirical testing and treatment for atypical bacteria in patients hospitalized with COVID, influenza, or RSV: a retrospective observational cohort study. [PDF]

Eur J Clin Microbiol Infect Dis
Hønge BL, Redder J, Greve T, Dalgaard LS, Sørensen AR, Ebdrup L, Mohey R, Tarp B, Holm M, Østergaard L, Storgaard M.   +10 more
europepmc   +1 more source

Helicobacter pylori eradication rate following first line non-bismuth quadruple therapy regimen in Tunisian patients: the HPERAD study. [PDF]

BMC Infect Dis
Fekih M, Jomni T, Ayari M, Battikh H, Zribi M, Labidi A, Serghini M, Ben Zid N, Hafi M, Boubaker J, Nciri A, Ben Abdelwahed M, Zakhama M, Loghmari MH, Baklouti R, Guediche A, Bouhlel W, Jemni I, Sabbek A, Chaabene NB, Safer L, Haddad O, Kadri Y, Rhim H, Mastouri M, Belhadj Mabrouk E, Mensi A, Ayadi S, Zaimi Y, Said Y, Mouelhi L, Debbeche R, Kchaou M, Haddad W, Chtourou L, Chabchoub H, Turki M, Njeh M, Mzid A, Medjahed N, Mnif B, Hammami A, Abdallah HB, Mohamed G, Abdelli N, Abdelaali I, Douggui MH, Medhioub M, Khsiba A, Mahmoudi M, Mohamed AB, Yakoubi M, Hamzaoui L, Azzouz MM, Bibani N, Trad D, Sabbah M, Jlassi H, Elloumi H, Gargouri D, Bouchabou B, Nakhli A, Hemdani N, Ennaifer R, Bel Hadj Ammar L, Nsibi S, Tlili R, Kallel L, Hamida SB, Elloumi H, Cheikh I, Nouira M, Ennigrou S.   +72 more
europepmc   +1 more source

Development of an HPLC method for the simultaneous determination of azithromycin, clarithromycin, and erythromycin in wastewater. [PDF]

RSC Adv
Duong TTA, Vuong TX, Ta TT, Nguyen TTL, Ngo TMV.   +4 more
europepmc   +1 more source

Exopolysaccharides of Streptococcus mutans Enhance Oral Colonisation and Drug Tolerance in Helicobacter pylori. [PDF]

Int Dent J
Hao Y, Huang Y, Chen R, Li Y, Huang X.
europepmc   +1 more source

Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial). [PDF]

Sci Rep
Sukkamolsantiporn S, Bongkotvirawan P, Chonprasertsuk S, Pornthisarn B, Siramolpiwat S, Bhanthumkomol P, Issariyakulkarn N, Gamnarai P, Wongcha-Um A, Aumpan N, Vilaichone V, Sornchuer P, Mahachai V, Miftahussurur M, Yamaoka Y, Kitipawong P, Vilaichone RK.   +16 more
europepmc   +1 more source

An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents. [PDF]

Helicobacter
Šterbenc A, Vratanar B, Mojškerc EM, Homan M.   +3 more
europepmc   +1 more source